Neurological impact of vasopressin dysregulation and hyponatremia

Keyphrases

• Dysregulation 100%
• Vasopressin 100%
• Neurological Effects 100%
• Hyponatremia 100%
• Na + 42%
• Arginine Vasopressin 28%
• Arginine Vasopressin Receptor Antagonists 28%
• Adverse Effects 14%
• Neurological Disorders 14%
• Brain Injury 14%
• Neurological Diseases 14%
• V2 Receptor 14%
• Pharmacological Agents 14%
• Clinical Experience 14%
• Serum Osmolality 14%
• Cerebral Edema 14%
• Common Cause 14%
• Controlled Experiment 14%
• Receptor Antagonism 14%
• Intracellular Compartments 14%
• Osmotic Demyelination 14%
• Urine Osmolality 14%
• Neurological Complications 14%
• Aquaresis 14%
• Tubular Reabsorption 14%
• Serum Sodium 14%
• Rapid Correction 14%
• Arginine Vasopressin Receptor 14%
• Electrolyte Balance 14%
• Osmotic Stimuli 14%
• Renal Collecting Ducts 14%
• Dilutional Hyponatremia 14%
• Water Balance 14%
• Antidiuretic Hormone 14%
• Free Water Clearance 14%
• Fluid Restriction 14%
• Inconsistent Responses 14%
• Treatment Agent 14%

Medicine and Dentistry

• Vasopressin 100%
• Hyponatremia 100%
• Sodium Ion 37%
• Argipressin Receptor 37%
• Neurologic Disease 25%
• Argipressin 25%
• Vasopressin Receptor Antagonist 25%
• Side Effect 12%
• Vasopressin V2 Receptor 12%
• Brain Injury 12%
• Brain Edema 12%
• Collecting Duct 12%
• Psychoactive Drug 12%
• Serum Osmolality 12%
• Free Water Clearance 12%
• Controlled Clinical Trial 12%
• Electrolyte Balance 12%
• Neurological Complication 12%
• Kidney Tubule Absorption 12%
• Demyelination 12%
• Neurosurgery 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Hyponatremia 100%
• Vasopressin 100%
• Sodium Ion 37%
• Argipressin Receptor 37%
• Argipressin 25%
• Neurologic Disease 25%
• Vasopressin Receptor Antagonist 25%
• Side Effect 12%
• Vasopressin V2 Receptor 12%
• Brain Injury 12%
• Brain Edema 12%
• Psychotropic Agent 12%
• Controlled Clinical Trial 12%
• Neurological Complication 12%
• Demyelination 12%